返回 Agenda
Opening Keynote Panel: The Future of Medical Affairs
Session Chair(s)
Rebecca A. Vermeulen, RPh
Vice President, Global Patient Networks | PD Medical Affairs
Genentech, A Member of the Roche Group, United States
Medical Affairs continues to forge a new role as a strategic pillar for healthcare product and innovation. Teams within medical affairs support critical aspects of the drug development lifecycle. With these new responsibilities, challenges emerge. This keynote panel will highlight perspectives on how medical affairs will change the landscape for drug development. Panelists will provide insights on how medical affairs will continue to impact patients’ needs, while providing recommendations for engaging global scientific experts to drive product development.
Learning Objective :
At the conclusion of this opening keynote panel, participants should be able to:
- Discuss the evolution of the medical affairs role and its impact in the drug development landscape
- Identify the role medical affairs plays in impacting the needs of patients
- Identify ways in how to engage globally with scientific experts to help drive the development of products
Speaker(s)
Speaker
Alexandra Zemp, PhD
McKinsey & Company, Inc., Switzerland
Partner
Speaker
Kirk Taylor, MD
EMD Serono, United States
Senior Vice President, North American Medical Affairs